ESR1 and gastric cancer: Indeed, we found that breast cancer patients with high expression levels of Vps11/18 have a higher probability of relapse-free survival (Fig. 7a, b), For gastric cancer, which is ERα-independent, the clinical value of high expression of Vps11/18 is exactly opposite (Fig. 7c, d).